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A variety of chromatin remodeling complexes are thought to orchestrate transcriptional programs that lead neuronal precursors from
earliest commitment to terminal differentiation. Here we show that mammalian neurons have a specialized chromatin remodeling
enzyme arising from a neurospecific splice variant of LSD1/KDM1, histone lysine specific demethylase 1, whose demethylase activity on
Lys4 of histone H3 has been related to gene repression. We found that alternative splicing of LSD1 transcript generates four full-length
isoforms fromcombinatorial retentionof two identified exons: the4aaexonE8a is internal to theamineoxidasedomain, and its inclusion
is restricted to the nervous system. Remarkably, the expression of LSD1 splice variants is dynamically regulated throughout cortical
development, particularly during perinatal stages, with a progressive increase of LSD1 neurospecific isoforms over the ubiquitous ones.
Notably, the same LSD1 splice dynamics can be fairly recapitulated in cultured cortical neurons. Functionally, LSD1 isoforms display in
vitro a comparable demethylase activity, yet the inclusion of the sole exon E8a reduces LSD1 repressor activity on a reporter gene.
Additional distinction among isoforms is supported by the knockdown of neurospecific variants in cortical neurons resulting in the
inhibition of neurite maturation, whereas overexpression of the same variants enhances it. Instead, perturbation of LSD1 isoforms that
are devoid of the neurospecific exon elicits no morphogenic effect. Collectively, results demonstrate that the arousal of neuronal LSD1
isoforms pacemakes early neurite morphogenesis, conferring a neurospecific function to LSD1 epigenetic activity.
Introduction
Chromatin represents the physiological substrate of epigenetic
regulation, underlying several biological processes, including
replication, transcriptional activity, and cell differentiation
(Kouzarides, 2007; Wu et al., 2009). In the CNS, chromatin inte-
grates a plethora of converging signaling pathways, leading to
short- and long-term changes in gene expression that are crucial
for neuronal commitment and terminalmaturation, as well as for
neuroplasticity throughout life (Walton et al., 1999; Tartaglia et
al., 2001; Borrelli et al., 2008). Although a variety of ubiquitously
expressed chromatin-remodeling complexes assist tissue-specific
transcription factors, neurorestricted chromatin-remodeling
factors have been identified only recently (Olave et al., 2002;
Barak et al., 2004; Lessard et al., 2007).
Lysine specific demethylase 1 [LSD1 (now named KDM1)]
(Allis et al., 2007) is a flavin-dependent histone demethylase that
specifically removes methyl groups from Lys4 of histone H3 (Shi
et al., 2004; Forneris et al., 2005a), relating this function to a wide
range of biological processes, such as development, differentia-
tion, cancer, andneurological disorders (Shi, 2007; Forneris et al.,
2008; Nottke et al., 2009). Its structure and function is conserved
from yeast to human (Dallman et al., 2004; Lakowski et al., 2006),
and it is typically associated to CoREST, a corepressor protein,
and histone deacetylasesHDAC1 andHDAC2 (Ballas et al., 2001;
Humphrey et al., 2001; You et al., 2001; Hakimi et al., 2002; Shi et
al., 2003). Human LSD1 consists of 852 amino acids and com-
prises an N-terminal SWIRM domain, involved in protein inter-
actions, and a C-terminal amine oxidase domain, which contains
an insertion that forms the CoREST interacting site (the so-called
“tower domain”) (Chen et al., 2006; Stavropoulos et al., 2006).
The three-dimensional structure of LSD1 in a ternary complex
with its histone peptide substrate and CoREST has been solved,
providing an explanation for the biological relevance of CoREST
inmediating substrate binding and recognition (Yang et al., 2006;
Forneris et al., 2007). Mechanisms that tune LSD1 activity have
been extensively investigated, including interactions with protein
partners (Lee et al., 2005; Shi et al., 2005) and concomitant mod-
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ifications on histone tail residues surrounding the demethylation
site (Forneris et al., 2005b; Forneris et al., 2006).
Given the central role of LSD1 in chromatin remodeling, we
investigated the process of alternative splicing on LSD1 as addi-
tional regulatory mechanism. Alternative splicing occurs at
higher frequency in singleton genes than multigene families
(Kopelman et al., 2005; Xing et al., 2006), and LSD1 displays a
unique paralog in the human genome AOF1 (now named
KDM1B) (Shi et al., 2004; Karytinos et al., 2009). Here, we report
the identification and functional characterization of four
mammal-specific LSD1 isoforms generated by either single or
double inclusion of two alternatively spliced exons, E2a and E8a.
Interestingly, although the inclusion of E2a is an event occurring
in all tissues, the isoforms retaining E8a display a neurospecific
pattern of expression, dynamically regulated during mammalian
brain development and synaptic maturation: in such critical
phases, a fine balance of LSD1 isoforms allows differentiating
neurons to acquire a proper morphology.
Materials andMethods
Total RNA extraction, reverse transcription-PCR, and quantitative reverse
transcription-PCR analysis. Total RNA was isolated using the RNeasy
Mini Kit (Qiagen), and the purified RNA was treated with RNase-free
DNase set (Qiagen) to remove any residual DNA. Quantitative reverse
transcription (qRT)-PCR analysis was performed on an iQ5 Real-Time
PCRDetection System (Bio-Rad) using the iScriptTM two-Step RT-PCR
Kit with SYBR Green (Bio-Rad). The relative expression of the investi-
gated genes was quantified after normalization against -actin. RT-PCR
was performedwith BioTaqDNAPolymerase (Boline) with primer pairs
reported in supplemental Table 1 (available at www.jneurosci.org as sup-
plemental material).
Evaluation of splicing inclusion events by relative quantity fluorescent-
PCR. To quantitatively measure the relative amount of each isoform, we
used a PCR-based method in which a fluorochrome-conjugated (FAM)
forward primer (Sigma-Aldrich) and a reverse unmodified onewere used
to amplify all the expected isoforms in a single reaction. PCR products,
mixed together with a suitable internal lane ROX-conjugated size stan-
dard (500ROX Standard; Applied Biosystems), were separated by capil-
lary electrophoresis under denaturing conditions, and the amount of
each amplified product was measured as microsatellite sample, based on
related fluorescence unit levels using the software GeneMapper. For a
more detailed protocol, see supplemental Material and Methods (avail-
able at www.jneurosci.org as supplemental material).
Cell culture, transient transfections, and reporter gene assays.HeLa cells
were cultured and transfected as described previously (Andres et al.,
1999); the experiments were performed 48 h after transfection. 5xUAS–
TK–LUC reporter plasmid (Chen et al., 1998) was used at 1:1, 1:0.125,
1:0.06, and 1:0.03 molar ratio relative to the expression plasmids pGal4–
LSD1 and pGal4–LSD1-8a. Control experiments were performed by us-
ing equivalent molar amounts of empty vectors. DNA was kept constant
by adding pBSIIKS (Stratagene) in every experiment; 0.05 g of pRL–
TK–vector (Promega) reporter vector was cotransfected to normalize for
transfection efficiency. The luciferase reporter activity was determined
with the Dual-Luciferase reporter assay system (Promega) according to
the instructions of the manufacturer. For each construct, the values of
Firefly luciferase were normalized over Renilla luciferase (both expressed
as relative luminescent units). The activity of each construct was ex-
pressed as a percentage of the promoter-less plasmid pGal4–vector.
Coimmunoprecipitation assay. Coimmunoprecipitation (IP) experi-
ments were performed as reported previously (Battaglioli et al., 2002).
HeLa cells were harvested 48 h after transfection in IP buffer (10% glyc-
erol, 0.5 mM EDTA 0.5% Triton X-100, 1 mM PMSF, and 1 protease
inhibitor cocktail (Sigma-Aldrich). Cellular extract (0.5 mg was reacted
with 1.25 g of rabbit polyclonal anti-CoREST antibody (Millipore),
mouse monoclonal anti-hemagglutinin (HA) (Santa Cruz Biotechnol-
ogy), or 1.25 g of mouse monoclonal anti-green fluorescent protein
(GFP) (Roche Molecular Biochemicals) with overnight rocking at 4°C.
The immunoprecipitates were collected with rProtein G Agarose (In-
vitrogen). After incubation, the beads were washed four times with the IP
buffer containing 5% glycerol and 0.1% Triton X-100. The immunopre-
cipitates were then eluted with 2 SDS sample buffer and analyzed by
Western blot.
Immunoblot assay and antibodies. Electrophoretically separated pro-
teins from lysates (input) or immunoprecipitates were transferred from
denaturing polyacrylamide gels to pre-equilibrated nitrocellulose mem-
brane (Schleicher& Schuell). SigmaMarkerHigh range (Sigma-Aldrich),
whosemolecular weight ranged from 36,000 to 200,000 kDa, was used to
characterize the migration of LSD1 doublet.
Themembranes were blocked in Tris-buffered saline and 0.1%Tween
20 (TBST) containing 5% nonfat dry milk and reacted at 4°C overnight
with appropriate primary antibody in TBST with 5% dry milk, rinsed,
and incubated with appropriate secondary antibody horseradish perox-
idase conjugate, developed with ECLWestern Blotting detection reagent
(Pierce Thermo Fisher Scientific), and revealed with x-ray films (East-
man Kodak).
Antibodies used included the following: CoREST (Millipore), HA
(Santa Cruz Biotechnology), HDAC2 (Millipore), panLSD1 antibody
(Diagenode), Shank (NeuroMab), and C-terminus-binding protein
(Cell Signaling Technology). Guanylate kinase domain-associated pro-
tein (GKAP), glutamate receptor-interacting protein (GRIP), and
calcium/calmodulin-dependent serine kinase (CASK) (rabbit; gifts from
M. Sheng), neuronal nitric oxide synthase (nNOS) (Santa Cruz Biotech-
nology), GluR1 (Oncogene), and GluR2/3 (Millipore Bioscience Re-
search Reagents). Antibody against E8a-containing isoforms was
generated as follows: a peptide containing exon E8a GQADTVKVPKE
was synthesized, injected into rabbits, and used to prepare peptide affin-
ity columns for antibody purification from antisera by Primm.
Expression and purification of recombinant LSD1 splice variants. Re-
combinant human LSD1 splice variants were expressed as truncated pro-
Table 1. Kinetic parameters for LSD1 and the splicing variants
kcat (min
1)a Km (M)
a
LSD1 CoREST 7.35 0.28b 5.12 1.04b
LSD1-2a CoREST 9.38 0.65 6.31 1.44
LSD1-8a CoREST 5.19 0.48 4.55 1.65
LSD1-2a/8a CoREST 5.47 0.20 7.52 1.00
aApparent steady-state kinetic parameters were determined as described by using a 21 aa H3 peptidemonomethy-
lated at Lys4 (Forneris et al., 2005).
bData were taken from Forneris et al. (2007).
Table 2. Data collection and refinement statistics
LSD1-8a CoREST complex with H3 inhibitor peptidea
Space group I222
Unit cell (Å) a 119.7
b 181.2
c 233.4
Resolution (Å) 3.0
Rsym
b,c (%) 11.3 (49.7)
Completenessc (%) 98.9 (99.8)
Unique reflections 50,357
Redundancy 4.1 (4.1)
I/c 10.2 (2.1)
Rcryst
d (%) 20.7
Rfree
d (%) 24.9
RMS bond length (Å) 0.017
RMS bond angles (°) 1.81
aThe finalmodel consists of residues 171-836 of LSD1-8a (including residues Asp-Thr-Val-Lys corresponding to exon
8a, which are inserted after Ala369 and are named 369A-369B-369C-369D), a FAD molecule, residues 308-440 of
CoREST, and residues 1-16 of the Lys4Met peptide.
bRsymIiI/Ii, where Ii is the intensity of ith observation andI is themean intensity of the reflection.
cValues in parentheses are for reflections in the highest resolution shell.
dRcryst Fobs Fcalc/Fobs, where Fobs and Fcalc are the observed and calculated structure factor amplitudes,
respectively. The set of reflections used for Rfree calculations and excluded from refinement was extracted from the
structure factor file relative to the Protein Data Bank entry 2IW5.
2522 • J. Neurosci., February 17, 2010 • 30(7):2521–2532 Zibetti et al. • Alternative Splicing Tunes LSD1/KDM1 Epigenetic Activity
teins lacking the N-terminal 122 residues, following the same protocols
used for the conventional isoform (Forneris et al., 2005a). Proteins were
purified by affinity chromatography, taking advantage of the N-terminal
His6 purification tag. The tag was then removed by cleavage with tobacco
etch virus protease. During protein purification, SDS-PAGE analysis
showed that the LSD1 proteins were subject to rapid precipitation and
unrecoverable degradation. Theproblemwas solvedbycopurificationwith
a C-terminal fragment (residues 305-482) of recombinant CoREST by
tandem-affinity chromatography as described previously (Forneris et al.,
2007). The resulting LSD1–CoREST complex is stable at 4°C for several
weeks as judged by SDS-PAGE and activity assays (see next section).
Biochemical assays. The enzymatic activities of LSD1 splice variants
were measured at 25°C using a Cary 100 UV/Vis spectrophotometer
(Varian) following published protocols (Forneris et al., 2005a) (Table 1).
Methylated synthetic peptides corresponding to the 21 aaN-terminal tail
of histone H3 were used as substrates for biochemical analysis (pur-
chased from Thermo Fisher Scientific).
Crystallization and structure determination. Samples of purified hu-
man recombinant LSD1 splice variants in complex with CoREST in 25
mM potassium phosphate, pH 7.2, and 5% (w/v) glycerol were concen-
trated using an Amicon Ultra concentration device (Millipore) to a final
concentration of 8mg/ml. Crystals were grown
at 20°C by hanging-drop vapor diffusion
method by mixing equal volumes of protein
samples with reservoir solutions containing 1.2
M sodium/potassium tartrate and 100 mM
N-(2-acetamido)iminodiacetic acid, pH 6.5
(Forneris et al., 2007). Crystals were trans-
ferred in a solution containing 1.6 M sodium/
potassium tartrate, 100 mM N-(2-acetamido)-
2-iminodiacetic acid, pH 6.5, 10% glycerol,
and 2 mM Lys4Met H3 peptide (i.e., the 21
N-terminal residues of H3 with Lys4 mutated
to Met) and flash cooled in liquid nitrogen.
Data collections were performed at the beam-
lines ID14-EH1 and ID23-EH2 of the Euro-
pean Synchrotron Radiation Facility. Data
processing was performed using the program
MOSFLM (Leslie, 1999) and CCP4 (Collabo-
rative Computational Project, Number 4,
1994). The structures of the LSD1–CoREST
complexes were solved by molecular replace-
ment using the program AMORE of the CCP4
suite. The initial search model was generated
from the Protein Data Bank entry 2IW5, de-
prived of cofactors, substrates, and ligands. Re-
finement was performed out using Refmac5
(Murshudov et al., 1997). Data collection and
refinement statistics are reported in Table 2.
Structure analysis, validation, and modeling
were performed using the program COOT
(Emsley and Cowtan, 2004). Figures were gen-
erated with PyMOL (www.pymol.org).
Cortical neuron cultures and immunostain-
ing. The cortical neuron cultures were pre-
pared from embryonic day 18 (E18) to E19 rat
brain (Charles River) as described previously
(Romorini et al., 2004), plated on 18-mm-
diameter coverslips, and grown on 12-well
plastic tissue culture plates (Iwaki; Bibby Steri-
lin). The neurons were transfected using cal-
cium phosphate precipitation (transfection
efficiency of 1%). Cells were fixed with a PBS
solution containing 4% paraformaldehyde for
10 min. Cells were incubated with anti-HA (1:
100; sc80; Santa Cruz Biotechnology) for 3 h in
GDB buffer (30 mM phosphate buffer, pH 7.4,
containing 0.2% gelatin, 0.5% Triton X-100,
and 0.8 M NaCl), followed by 1 h incubation
with cyanine 3-conjugated secondary antibody
(The Jackson Laboratory) and mounted in VectaDAPI medium (Vector
Laboratories). Images were acquired on a Carl Zeiss LSM5 510 laser-
scanning confocal microscope (generously donated by Fondazione
Monzino) at 63magnification. Morphometric analysis was performed
using NIH ImageJ software.
Results
Identification of novel LSD1 isoforms evolutionarily
conserved in mammals
The annotated human LSD1 gene (also known as AOF2) se-
quence (GenBank accession number NM_015013) encodes for
anmRNA that results from the fusion of 19 exons and gives rise to
a protein of 852 aa (Fig. 1A). To further investigate the structure
of the LSD1 gene, we performed an analysis of its genomic region
using GenomeVISTA tools, comparing human and mouse LSD1
genes (Fig. 1B). We found a very high conservation degree
(95%) in correspondence of the known 19 exons and a lower
conservation in all the flanking intronic sequences.However, two
regions located inside introns 2–3 and 8–9 emerged for the high-
Figure 1. Genomic organization of human LSD1 gene. A, Schematic representation of the human LSD1 protein domains to-
gether with its exons ranging from 1 to 19; asterisks indicate the location of annotated alternative exons (E2a and E8a). Different
colors in grayscale indicate functional domains. N-terminal unstructured region (white) coded by exons 1–2, SWIRM domain
(black) coded by exons 2–4, the SWIRM-oxidase connector (black striped) coded by exon 5, the amine oxidase domain (gray),
coded by exons 6–9 and exons 13–19, and the tower domain (gray striped) coded by exons 10–12. ResidueMet1 of this sequence
corresponds to the first amino acid of the protein characterized (Shi et al., 2004). B, Human AOF2 alignment across vertebrates by
GenomeVista browser (http://pipeline.lbl.gov/cgi-bin/GenomeVista). The “peaks and valleys” graphs represent percentage
conservation at a given genomic coordinate between aligned sequences and the human sequence. Human exons are
numbered. The top and bottom percentage bounds are shown to the right of every row. Regions of high conservation are
colored as exons (dark gray) or noncoding (light gray). Conserved regions are defined as regions with identity of 70% or
higher that are wider than or equal to “minimal conservation width” (100 bp). C, Enlarged view of 650 bp of the alignment
between human and mouse intronic regions containing the two alternatively spliced exons (E2a and E8a) and one consti-
tutively included exon (E13). Highlighted bars above the conservation area correspond to annotated E2a, E8a, and E13 of
human AOF2. Dark gray areas within the conservation graph mark exons; light gray areas mark conserved (above 70%)
nonexonic sequences.
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est homology (Fig. 1B,C), indicating the possible existence of two
additional exons subject to alternative splicing within these con-
served intronic sequences. On this basis, we performed a search
in the University of California, Santa Cruz database (version
March 2006) and found an additional known gene (GenBank
accession number BC040194; IMAGE identification number
4815528) related to AOF2 gene transcript. Such sequence, de-
rived from an mRNA expressed in human hippocampus, con-
tained two yet undescribed exons that we named exons 2a and
8a (E2a and E8a). E2a is 60 bp long and encodes for 20 aa,
whereas the E8a is 12 bp long and is translated into 4 aa with
sequence Asp-Thr-Val-Lys. The inclusion of the two exons
does not alter the reading frame and results in a protein of 876
aa that we named LSD1-2a/8a. In this LSD1 isoform, the
amino acids coded by E2a localize between the N-terminal
disordered region and the SWIRM domain, whereas the four
residues of E8a immediately precede the CoREST-binding
tower domain, which is inserted within the amine oxidase
domain (Fig. 1A). The alternatively spliced introns present
canonical donor/acceptor splice sites (supplemental Table 1,
available at www.jneurosci.org as supplemental material) and
display a very high conservation degree between human and
mouse (Fig. 1C), a typical feature of alternatively spliced exons
(Sorek and Ast, 2003).
An extended search for partial and complete transcripts
containing one or both identified LSD1 exons was performed
in the genomic sequences of different mammalian species,
based on human LSD1 mRNA (GenBank accession number
BC040194) (http://www.ncbi.nlm.nih.gov/BLAST/): all inves-
tigated species displayed at least one alternative exon, and,
most importantly, all E8a-containing expressed sequence tags
(ESTs) turned out to derive from the nervous system, as shown
in supplemental Table 2 (available at www.jneurosci.org as
supplemental material). We extended our analysis to other
vertebrates to compare AOF2 gene structure throughout evo-
lution. Whereas E2a was present and highly conserved in liz-
ard (data not shown), chicken, and mammals, E8a is fully
preserved in mammals only.
Figure 2. Mammalian LSD1 transcript undergoes alternative splicing and produces four isoforms with different tissue distribution. A, Exon structure of the mammalian LSD1 gene and position
of theprimers used to identify full-length, polyadenylated transcripts characterizedby thepresence or absence of E2a andE8a. Primers are indicated as F for forward or R for reverse, and thenumbers
indicate the exonswhere each primer anneals. Total RNA from human adult tissues (B) and total RNA frommouse adult brain tissues (D) were tested for LSD1 splicing variant expression by RT-PCR.
The cDNA were amplified with primers covering the entire coding sequence (primers 1F and 19R) and reamplified with two different nested PCR, one including E8a (PCR1) and one excluding E8a
(PCR2). -Actin was used as control. C, Structure of the four LSD1 variants. E, F, Isoform-relative quantification of LSD1 splicing variants in mouse brain areas, primary neuronal cultures, and
astroglia. rqf-PCR on cDNA obtained from total RNA of the indicated samples. Amplicons were quantified by related fluorescence units (RFU) by GeneMapper software and graphed as percentage
relative to the sumof all the isoforms. Neurospecific LSD1 isoforms are shown in black and dark gray, whereas ubiquitous ones are shown in light gray andwhite.G, Splicing generates four different
LSD1proteins.Western blots of total protein extracts frommousebrain andheart probedwith apanLSD1antibody andmigration of recombinant LSD1 isoforms transfected inHeLa cells probedwith
anti-HA antibody. All the indicated samples were run on the same polyacrylamide gel. H, Anti-LSD1-8a antibody specificity was assessed by Western blot on total protein extracts from heart and
brain rat tissues and HeLa cells transfected with pCGN vector (mock), HA-tagged LSD1, or HA-tagged LSD1-8a cDNAs.
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Exon E8a-retaining LSD1 splice variant is restricted to
neuronal lineage
The existence of an annotated human mRNA containing both
E2a and E8a in an open reading frame prompted us to further
analyze alternatively spliced isoforms containing the identified
exons and to characterize their transcriptional profile on several
samples derived from human, mouse, and rat tissues. The pres-
ence of LSD1 splicing isoforms was first investigated in a panel of
total RNA samples from adult human tissues and cell lines (Fig.
2A,B) (supplemental Fig. 1, available at www.jneurosci.org as
supplemental material). Through selective amplification of iso-
forms containing E8a (hPCR1), we found that LSD1-2a/8a was
present in brain and testis, whereas the LSD1 with the sole E8a
(LSD1-8a) was detected exclusively in
brain tissues. Conversely, the amplifica-
tion of isoforms excluding E8a (Fig. 2B,
hPCR2) gave two products in all ana-
lyzed tissues, indicating that native
LSD1 and LSD1-2a isoforms are ubiqui-
tously expressed (see scheme in Fig. 2C).
The identification of four mRNA species
transcribed from the human AOF2 gene
indicates that (1) retention of E2a and E8a
are two independent events, and (2) the
inclusion of E8a is a tissue-specific event
that occurs only in neuronal tissues and
testis.
We extended the characterization of
the tissue distribution of the four LSD1
splicing isoforms in adult mouse brain
using the same approach performed on
human tissues. As shown in Figure 2D,
all the analyzed areas coexpress the four
LSD1 isoforms. The overall amount of
LSD1measured by real-time qPCR showed
comparable amounts of LSD1 transcripts
in the different areas (data not shown). To
further refine our analysis, we set up a
method, namely rqf-PCR (for detailed
protocol, see supplemental data, available
at www.jneurosci.org as supplemental
material) in which coamplified LSD1 iso-
forms are analyzed at high resolution by
capillary electrophoresis (for an example
of two typical electropherograms, see
supplemental Fig. 2, available at www.
jneurosci.org as supplemental material).
This method allowed us to finely monitor
differences in the expression levels of
LSD1 isoforms among brain areas. This
analysis (Fig. 2D,E) revealed that the four
isoforms are similarly expressed in all in-
vestigated brain regions, suggesting a con-
trolled balance between the inclusion and
exclusion events within adult murine
CNS. Furthermore, because neuronal tis-
sues contain variable percentage of glial
components, we asked whether the pres-
ence of the neurospecific LSD1 (nLSD1)
doublet detected in all evaluated nervous
tissues might be attributable to neuronal
rather than glial histotype or both. There-
fore, we performed a fluorescent rqf-
PCR on selected rat primary cultures, that is hippocampal
neurons, cortical neurons, and cortical astroglia. The analysis
revealed that glia is completely devoid of nLSD1 isoforms but
retained the ubiquitous LSD1 (uLSD1) ones (Fig. 2F), whereas
both hippocampal and cortical neurons retain the full pattern
of the four identified isoforms, confirming that E8a inclusion
within nLSD1 variants strictly relates to the neuronal histo-
type. Because glial components (identified as GFAP-positive
cells) do not exceed 2–3% in the evaluated neuronal cultures
and the overall LSD1 protein levels did not appear to differ
between neurons and glia (data not shown), we conclude that
rqf-PCR quantification of coexisting LSD1 variants is reliably
attributable to neurons.
Figure 3. Comparative structural analysis of LSD1 and the LSD1-8a splice variant. A, Overall crystal structure of LSD1-8a–
CoREST in complex with a histone peptide. LSD1-8a (residues 171-840) is in light blue, CoREST (residues 308-440) in red, and the
histone H3 peptide (residues 1-16) in green. The FAD cofactor is in the orange ball-and-stick representation. The insertion site of
E8a (residues Asp369A-Thr369B-Val369C-Lys369D) is highlighted. B, Close-up view of LSD1-8a structure at the site of exon E8a
insertion. LSD1-8a structure is in blue, and it is superimposed onto native LSD1 (yellow; Protein Data Bank entry 2v1d) (Forneris et
al., 2007). The orientation of the proteins is the same as in Figure 3A. The side chains of exon E8a residues are labeled in bold. Exon
E8a insertion protrudes from the main body of the protein.
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Alternative splicing generates four functional proteins
Rat brain and heart tissues were assayed for the expression of
LSD1 by SDS-PAGE. Immunoblotting by a panLSD1 antibody
revealed a discrete doublet of 	110 kDa in both tissues (Diage-
node). The doublet was further characterized by comparing
the migration of endogenous LSD1 with tagged isoforms that
were individually transfected in HeLa cells. As shown in Figure
2G, the isoforms that contain exon E2a (LSD1-2a and LSD1-2a/8a)
are upper shifted from the isoformswithout it (LSD1 andLSD1-8a).
The electrophoresis mobility displayed by the tagged LSD1 iso-
forms resumes the migration pattern of endogenous LSD1 pro-
teins, hence suggesting that the doublet shared by andobserved in
neuronal and non-neuronal tissues is most probably attributable
to the presence and absence of exon E2a (20 aa long) within
LSD1. Nonetheless, we do not exclude that posttranslationally
modified LSD1 isoforms may reside underneath the bands of the
identified doublet.
Furthermore, because inclusion of the sole exon E8a (4 aa
only) produces no detectable variation in electrophoretic mobil-
ity of the 110 kDa protein, the LSD1 and LSD1-2a cannot be
distinguished from LSD1-8a and LSD1-2a/8a, respectively. To
demonstrate the existence of endogenous proteins containing the
exon E8a, we produced an antibody specifically raised against a
short peptide containing the amino acids Asp-Thr-Val-Lys (exon
E8a sequence). The anti-E8a antibody specificity was tested by
ELISA against the recombinant proteins (data not shown) as well
as against the transfected cDNAs in HeLa cells (Fig. 2H). This
antibody detected the presence of E8a-containing isoforms in rat
brain tissues but not in heart, confirming that the four mRNA
generated by alternative splicing are indeed translated in four
proteins.
Effect of E2a and E8a inclusion on LSD1 enzymatic activity in
vitro and three-dimensional structure
To analyze the enzymatic activity of the four different LSD1 splice
variants, we expressed three human recombinant LSD1 isoforms
(LSD1-2a/8a, LSD1-2a, LSD1-8a) and we performed compara-
tive biochemical assays using histone H3 peptides. Both E2a and
E8a had a strong destabilizing effect on the purified recombinant
LSD1, which prevented their further biochemical investigation.
Fortunately, in vitro reconstitution of the complex formed by
LSD1 with the corepressor protein CoREST by tandem-affinity
purification strategies (Forneris et al., 2007) provided far more
stable protein samples, enabling their structural and biochemical
characterization. This finding indicated that the splicing vari-
ants retain the ability to form a stable complex with CoREST.
Biochemical assays using histone H3 peptides revealed that all
three LSD1 isoforms bound to CoREST can demethylate Lys4 of
histone H3 with a catalytic efficiency virtually identical to that
displayed by conventional LSD1 (Table 1). Moreover, they are
totally inactive on peptides monomethylated on Lys9, demon-
strating that alternative splicing does not affect substrate speci-
ficity. We further investigated the recombinant LSD1-2a/8a,
LSD1-2a, and LSD1-8a proteins by x-ray crystallography. Crys-
tals of their complex with the C-terminal region of CoREST (res-
idues 305-482) and a 21 aa H3 peptide were obtained under
identical conditions to those used for LSD1 protein (Forneris et
al., 2007) (Fig. 3A). We found that, as for the native enzyme, also
in the splicing variants, the N-terminal residues preceding
Pro171 are disordered andnot visible in the electron densitymap.
This finding implies that, even in the presence of exon E2a (in-
serted between residues 170 and 171), the N-terminal region of
LSD1 remains unstructured, at least in the crystalline state.
Therefore, the structures containing E2a were indistinguishable
from those lacking this insertion, and we shall focus our structural
analysis to LSD1-8a in complex with CoREST and the histone
peptide.
The overall conformation of LSD1-8a is very similar to that of
the native protein with a root-mean-square deviation of 0.30 Å
for 666 C atoms. The E8a residues Asp-Thr-Val-Lys inserted
Figure 4. Effect of the included exon E2a and/or E8a on LSD1 repressor activity and affinity
for corepressor partners. A, The four indicated LSD1 splice variants fused to Gal4–DBD were
assayed for their ability to repress a reporter gene onHeLa cells at a constant reporter/repressor
molar ratio. B, In rat cortical neurons, LSD1 and LSD1-8a were compared at different reporter/
repressor molar ratios. The luciferase activity normalized over the activity of a cotransfected
renilla reporter is expressed as percentage of the activity of the Gal4–DBD vector at eachmolar
ratio. Values are derived from at least three independent experiments. In A andB, a Student’s t
test (l Stat t I T/2) was applied to percentage values by comparing splicing isoforms with
LSD1. *p 0.05; **p 0.01; ***p 0.001. C, Whole-cell immunocomplexes fromHeLa cells
overexpressing the indicatedHA–LSD1 isoformswere obtainedbyHAantibodies and separated
by SDS-PAGE. The Western blots were probed with antibodies to HA, CoREST, and HDAC2.
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between Ala369 and Asp370 of the conventional isoform gener-
ate an antiparallel -turn located in proximity of one of the two
helices that define the tower domain (Fig. 3A). Structural super-
positions show that the presence of E8a does not cause any local
conformational change (Fig. 3B). Likewise, the conformations of
CoREST and of the bound histone peptide are identical to those
observed in the structure of LSD1–CoREST–peptide complex.
The exon residues are located on the rim of the open cleft that
forms the substrate-binding site, but they are not in direct contact
with either the histone peptide or CoREST (Fig. 3A). This obser-
vation is in agreement with the biochemical evidence that the
enzymatic activity and substrate specificity of LSD1 splice vari-
ants are very similar to those of conventional LSD1 (Table 1). It is
noteworthy that the E8a residues form a sort of protrusion that
emerges from the main body of the protein. Such a feature indi-
cates that these residues could easily form a docking site for other
protein partners, which remain to be identified.
Inclusion of the neurospecific E8a exonmodulates LSD1
repressive activity on a reporter gene
Because LSD1 repressive function on target genes has been as-
sessed previously (Shi et al., 2004), we wanted to determine
whether the inclusion of either exon E2a or E8a in LSD1 isoforms
might alter its activity. Therefore, we transfected LSD1 splice
isoforms in different cellular systems and compared their effect
on luciferase reporter gene. As shown in Figure 4A, in HeLa cells,
the inclusion of exon E2a does not cause any change in luciferase
expression (LSD1-2a vs LSD1, 1.31  0.48 vs 1.12  0.24; p 
0.34, t test), whereas the presence of exon E8a results in a signif-
icantly reduced repression of luciferase reporter, as evaluated in
the HeLa cell line (LSD1-8a vs LSD1, 3.11 1.16 vs 1.12 0.24,
p 0.008; LSD1-2a/8a vs LSD1, 4.17 0.78 vs 1.12 0.24, p
5.3e16, t test). Differences in repressive activity were further
evaluated on a scale of reporter: repressor molar ratios in HeLa
and SH-SY5Y cell lines (supplemental Fig.
3, available at www.jneurosci.org as sup-
plemental material). Notably, also in rat
cortical neurons, in which the neuronal
LSD1 isoforms are physiologically ex-
pressed, LSD1-8a and LSD1 exhibit dif-
ferent repressor properties (LSD1-8a vs
LSD1 in Fig. 4B at a molar ratio 1:0.5,
89.41  2.82 vs 69.99  5.68, p  0.018;
molar ratio 1:1, 64.16  4.01 vs 43.85 
3.22, p 0.029, t test).
All recombinant LSD1 splice
isoforms can be assembled into
a CoREST complex
The corepressor activity of LSD1 depends
in part on the multiprotein complex to
which it belongs. Therefore, we tested
whether the presence of E2a, E8a, or both
might interfere with the formation of
the complex with CoREST and associated
proteins. Using anti-HA-antibody, we
isolated LSD1 immunocomplexes from
HeLa cells transfected with the four HA-
tagged LSD1 isoforms. In all isolated im-
munocomplexes, we were able to detect
the presence ofCoREST andHDAC2 (Fig.
4C). Furthermore, in brain extracts, LSD1
and CoREST take part to the same core-
pressor complex (supplemental Fig. 4A, available at www.
jneurosci.org as supplemental material). This finding, together
with the biochemical and structural data (Fig. 3), demonstrate
that inclusion of either exon does not preclude LSD1 interac-
tion with knownmolecular partners and that LSD1 splice vari-
ants can function as corepressor factors similarly to the
conventional isoform.
A mechanism to explain the functional implication of the LSD1
isoformsdiversitymight arise fromthe combinatorial incorporation
of different isoforms. Indeed, assembly of higher-order HDAC1/2
complexes requires two heterotrimers each formed by CoREST,
LSD1, and either HDAC1 or HDAC2 (Humphrey et al., 2001).
Therefore, we tested whether different isoforms might be incorpo-
rated into the same higher-order HDAC1/2 complex. HeLa cells
were cotransfectedwithGFP-tagged LSD1 alongwith differentHA-
tagged LSD1 isoforms. Supplemental Figure 4B (available at www.
jneurosci.org as supplemental material) shows that it is possible to
form hetero-oligomeric complexes in which different LSD1 iso-
forms are incorporated.
Expression of neurospecific LSD1 isoforms is regulated
throughout brain development
Because inclusion of E8a is a neurorestricted event, we inferred its
function within CNS by relating its expression profile to peculiar
stages of neuronal differentiation. Time course analysis of the
relative amount of each LSD1 splice isoform was performed by
rqf-PCR. Rat cortical tissues were collected at several develop-
mental stages and analyzed (Fig. 5A,B). At early embryonic
stages, all of the four LSD1 isoforms are detectable, with prepon-
derant expression of the LSD1 and LSD1-2a (42 and 38%, respec-
tively; data not shown) over neurospecific isoforms (LSD1-8a
and LSD1-2a/8a, 12 and 8%, respectively; data not shown). Later
on, within the perinatal window between E18.5 and postnatal day
1 (P1), a rapid inversion of the proportions occurs: E8a-
Figure 5. Inclusion of neurospecific E8a in LSD1 transcripts is dynamically modulated during neuronal development, whereas
inclusion of E2a is a steady event. The relative amount of each LSD1 isoformwas measured by rqf-PCR; cDNA were obtained from
total RNA from rat embryonic cortex (E18.5), postnatal rat cortex (PN), and adult rat cortex. Graphs represent the relative percent-
age of each isoform with respect to the sum of the four. Only two isoforms are shown per graph; A compares LSD1 isoform with
LSD1-8a, whereas B compares LSD1-2a isoform with LSD1-2a/8a. Values shown are mean SD. C, Exon inclusion frequency of
exons E2a and E8a. Each represented series relates to the overall inclusion of either E8a (black squares) calculated as the sum of
LSD1-2a/8a and LSD1-8a relative percentage and E2a (white squares), calculated as sum of LSD1-2a and LSD1-2a/8a relative
percentage, at each indicated developmental stage. D, Total LSD1 transcript quantification by qRT-PCR on total RNA extract from
the indicated rat cortex samples normalized on-actin. Samples are expressed as fold increase relative to the LSD1 value at E18.5.
Western blot on total protein samples from the indicated development cortical stages with a panLSD1 antibody or neurospecific
LSD1 antibody (E) and with the indicated synaptic markers (F ).
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containing isoforms undergo a threefold
increase shifting from 12 to 50% and from
8 to 25%, respectively, with a concomitant
threefold decrease of LSD1 and LSD1-2a
isoforms (Fig. 5A,B), and preponderance
of E8a-containing isoforms is maintained
until P7. Thereafter, LSD1 isoforms reach
comparable levels and stabilize to the val-
ues measured in adult cortical cortex
(compare with Fig. 2E). Time course
analysis performed on cerebellar tissues
revealed a similar expression pattern of
LSD1 splice isoforms (data not shown).
From these data, we calculated the in-
clusion frequency of either exon during
development. Inclusion frequency of
E2a, derived from the sum of LSD1-2a
and LSD1-2a/8a (Fig. 5C, white squares),
is rather constant, whereas the inclusion
of E8a, calculated as the sum of LSD1-8a
and LSD1-2a/8a (Fig. 5C, black squares),
appears to be developmentally regulated.
Overall LSD1 transcription and protein
levels decrease between E18.5 and P1 and
remain stable along subsequent stages of
development (Fig. 5D,E). Because astro-
glia express only the ubiquitous isoforms
(LSD1 and LSD1-2a) (Fig. 2F), a decrease
in tissue glial composition may mislead-
ingly indicate an increase in neurospecific
isoforms (LSD1-8a and LSD1-2a/8a).
Therefore, we also analyzedGFAP expres-
sion inferring glial relative contribution to
isoform quantification. GFAP real-time
qPCR analysis was performed from E18.5
to postnatal stages (supplemental Fig. 5A,
available at www.jneurosci.org as supplemental material). Con-
sistent with previous reports (Qian et al., 2000; Fox et al., 2004),
GFAP is expressed at low levels in the perinatal window and
constantly increases during postnatal development. This demon-
strates that the detected increase of E8a is indeed caused by a
neurospecific splice event, with no regard to glial composition. A
parallel analysis showed that several synaptic markers arise dur-
ing the perinatal window (E18.5 to P1) with a progressive in-
crease over developmental stages (Fig. 5F), indicating that the
inclusion frequency of E8a increases concomitantly with early
stages of synaptogenesis.
Neurospecific LSD1 contributes to neurite morphogenesis
during early phases of cortical development
LSD1 expression profile suggests a possible implication of neu-
rospecific E8a-containing isoforms in neuronal development. To
test this hypothesis, we perturbed the expression of LSD1 iso-
forms within rat cortical neurons, which represent a suitable
model of neuronal maturation, as assessed through the expres-
sion of synaptic markers that mirror postnatal development (Fig.
6A) (Lee and Sheng, 2000; Sala et al., 2000). This model also
recapitulates the physiological expression pattern of LSD1 iso-
forms that we initially observed in vivo: the four LSD1 isoforms
are all detectable at day in vitro 0 (DIV0) (corresponding to rat
E18.5), with LSD1-2a and LSD1 being most abundant; as neuro-
nal maturation proceeds, neurospecific E8a-containing LSD1
isoforms progressively increase (DIV2) and become preponder-
ant (DIV6) (Fig. 6B,C). The overall inclusion frequency of either
exon confirmed that E8a inclusion is developmentally regulated,
whereas E2a inclusion does not change (Fig. 6D). Furthermore,
LSD1 protein level analyzed by a panLSD1 antibody showed the
same decrease during neuronal maturation that was observed in
vivo (Fig. 6E). Also in this case, we verifiedwhether any detectable
variation of LSD1 isoforms might be influenced by a change in
the proportion between neurons and glia during maturation in
vitro. As indicator of astroglial contribution, we measured GFAP
transcript, confirming (Fox et al., 2004) a persistently low expres-
sion from embryonal stage DIV0 (E18.5) to DIV4 and a robust
increase detectable not sooner than DIV8 (supplemental Fig. 5B,
available at www.jneurosci.org as supplemental material) that is
after the inversion of LSD1 isoforms proportion has occurred.
Again, we can reliably assume that the increase of E8a inclusion in
our cellular model is attributable to the neuronal differentiation,
with no regard to glial composition.
To infer the function of LSD1 isoforms within neurons, we
knocked them down differentially by generating short hairpin
RNAs (shRNAs) specific for either neurospecific exon E8a or the
splice junction between exon E8 and E9, which is shared among
ubiquitous LSD1 isoforms. Hairpins containing vectors were
generated and tested for isoform specificity and efficacy (supple-
mental Fig. 6, available at www.jneurosci.org as supplemental
material). Cortical neurons were transfected at DIV4 with hair-
pins containing vectors and analyzed at DIV8 (Fig. 7A–C). We
evaluated phenotypic traits that describe neuronal morphogene-
Figure 6. LSD1 splicing analysis in a rat cortical neuron maturation system. A, In vitromaturation of cortical neurons prepared
from E18.5 embryos (DIV0) was assessed byWestern blot analysis of the indicated synapticmarkers on total protein samples from
the indicated DIV. Graphs represent the relative percentage of each isoformwith respect to the sum of the four. Only two isoforms
are shown per graph; B compares LSD1 isoform with LSD1-8a, whereas C compares LSD1-2a isoform with LSD1-2a/8a. Values
shown are mean SD. D, Exon inclusion frequency of exons E2a and E8a. Each represented series relates to the overall inclusion
of either E8a (black squares), calculated as the sum of LSD1-2a/8a and LSD1-8a relative percentage, and E2a (white squares),
calculated as the sum of LSD1-2a and LSD1-2a/8a relative percentage, at each indicated developmental stage. E, Western blot on
total protein samples from the indicated DIV with a panLSD1 antibody.
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sis during in vitro maturation, including cumulative neurite
length, the number of branches, and neurite width by Sholl’s
analysis performed on increasing radii from centered soma (Fig.
7D–F) (Sholl, 1953). The knockdown of ubiquitous isoforms
ensued little or no effect when compared with control according
to cumulative neurite arborization, branch count, and neurite
width. Conversely, the silencing of neurospecific isoforms altered
neurite morphogenesis by eliciting a significant decrease of the
cumulative neurite arborization (Fig. 7D), a reduced number of
secondary branches (Fig. 7E), and a reduced average neurite
width (Fig. 7F). [The following series are scrambled compared
with shRNAvs8a or shRNAvs8/9 conditions with related p values:
neurite length (in m) in Figure 7D, 897.21  225.9, 664.42 
170.9, p 4.99e4; 1063.44 229.5, p 0.06; neurite branches in
Figure 7E, 11.08 1.54, 8.88 1.59, p 0.048; 11.16 2.13, p
0.95; neuritewidth (inm) inFigure 7F at inner radius, 1.420.12,
0.95  0.078, p  4.95e9; 1.29  0.14, p  0.16; intermediate
radius, 1.27 0.11, 0.85 0.074, p 7.21e9; 1.12 0.12, p
0.08; outer radius, 1.13 0.1, 0.79 0.064, p 1.01e6; 0.98
0.098, p 0.05; two tailed t test.]
Furthermore, we evaluated neurite morphogenesis after over-
expressing LSD1 neurospecific isoforms, because this was ex-
pected to exert opposite effects to those observed during
knockdown experiments. Neurons were transfected at DIV4with
enhanced GFP (EGFP) vector alone (mock condition) (Fig. 8A)
and cotransfectedwithHA-tagged LSD1 isoforms, both neuronal
(pCGN–LSD1-8a plus pCGN–LSD1-2a/8a indicated as nLSD1
condition in Fig. 8B) and ubiquitous ones (pCGN–LSD1 plus
pCGN–LSD1-2a indicated as uLSD1 condition in Fig. 8C). As
expected, overexpression of neurospecific isoforms induced an
increase in the morphometric parameters compared with con-
trols (Fig. 8D–F), whereas overexpression of ubiquitous iso-
forms did not result in any significant effect. [The following series
are mock compared with nLSD1 or uLSD1 conditions with re-
lated p values: neurite length (in m) in Figure 8D, 783.7 
116.9, 943.8 132.1, p 0.03; 799.9 101.5, p 0.41; neurite
branches in Figure 8E, 17.24  5.67, 23.92  4.64, p  0.03;
12.56  2.63, p  0.07; neurite width (in m) in Figure 8F at
inner radius, 0.835  0.09, 1.239  0.11, p  2.12e8; 0.855 
0.07, p 0.36; intermediate radius, 0.7339 0.09, 1.1313 0.11,
p 2.27e8; 0.7419 0.06, p 0.44; outer radius, 0.5995 0.08,
0.8876 0.07, p 2.01e7; 0.6225 0.05, p 0.32; one-tailed t
test]. To discern the relative contribution of each E8a-containing
isoform in mediating the morphogenic effect on neurons, we
performed a parallel experiment, transfecting either LSD1-8a or
LSD1-2a/8a. As shown in supplemental Figure 7 (available at
www.jneurosci.org as supplemental material), LSD1-8a is re-
sponsible for the morphogenic effect with LSD1-2a/8a partially
recapitulating the phenotype that was observed under the nLSD1
condition (Fig. 8) in which both isoforms were present.
Figure 7. Effect of neurospecific or ubiquitous LSD1 knockdown by shRNAs on neurite mor-
phology in rat cortical neurons. Cultured cortical neurons were transiently transfected with
pSuper GFP Neo control (scramble) (A), pSuper engineered with shRNA against exon E8a
(shRNA vs 8a) (B), and pSuper engineered with shRNA against the splice junction between
exons E8 and E9 (shRNA vs 8/9) (C). Morphology was analyzed for EGFP-positive neurons with
DAPI (4
,6
-diamidino-2-phenylindole) counterstain.D, Cumulative neurite length in differen-
tially LSD1 knocked down neurons is indicated as average SEM inmicrometers. E, Secondary
branches count is indicated SEM. F, Average neurite width by Sholl analysis calculated on
inner, intermediate, and outer Sholl’s circles corresponding to 20, 25, and 30m radii, respec-
tively. Values shownaremean SEMwidth inmicrometers. Student’s t test (l Stat t I T/2)
was applied to values by comparing each condition with control scramble. *p 0.05; **p
0.01; ***p 0.001. Scale bars, 20m.
Figure 8. Effect of overexpression of neurospecific or ubiquitous LSD1 isoforms on
neurite morphology in rat cortical neurons. Primary rat cortical neurons were transiently
cotransfected with pCGN vector (mock) (A), EGFP together with HA–LSD1-8a plus LSD1-
2a/8a (nLSD1) (B), HA–LSD1 plus LSD1-2a (uLSD1) (C). Morphology was analyzed in
EGFP-positive neurons (mock) or double-labeled EGFP- and HA-positive neurons. D, Cu-
mulative neurite length in differentially LSD1 transfected neurons is indicated as aver-
age SEM in micrometers. E, Secondary branches count is indicated SEM. F, Average
neurite width by Sholl analysis calculated on inner, intermediate, and outer Sholl’s circles
corresponding to 20, 25, and 30 m radii, respectively. Values shown are mean SEM
width inmicrometers. Student’s t test (l Stat t I T) was applied to values by comparing
each condition with mock. *p 0.05; **p 0.01; ***p 0.001. Scale bars, 20m.
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In conclusion, although the knockdown of neurospecific
LSD1 isoforms delays neurite morphogenesis, overexpression of
the same seems to anticipate features that normally arise at later
stages under physiological conditions. Conversely, perturbation
of ubiquitous LSD1 variants, either by knock down or transfec-
tion, sorted no statistically significant effect when compared with
controls. Because our conditions only differed for E8a retention
in both experiments, the morphogenic effects likely rely on exon
E8a presence.
Discussion
Alternative splicing is considered one of the most powerful bio-
logical mechanisms that convey diversification of gene function
without a corresponding increase in gene number (Kopelman et
al., 2005; Parmley et al., 2007), giving rise to evolutionary com-
plexity, especially formammalian species. Notably, most of splic-
ing events occur on CNS-related transcripts and participate in
fundamental nervous processes, from cell-related ones, such as
axon guidance and synapse formation (Lipscombe, 2005; Licata-
losi andDarnell 2006; Ule andDarnell, 2006), to higher cognitive
functions, including learning and memory (Grabowski and
Black, 2001). Although LSD1 function has been extensively in-
vestigated, its epigenetic role in the nervous system has not been
elucidated yet. Nonetheless, LSD1 involvement in neuronal pro-
cesses has been inferred through the transcriptional silencer
REST of which LSD1 is a known corepressor (Shi et al., 2004):
REST prevents the expression of neuron-specific genes outside
CNS, regulating it throughout neurogenesis (Ballas et al., 2005).
REST is also expressed in the adult nervous system (Palm et
al., 1998; Garriga-Canut et al., 2006), in which its repressor func-
tion can be modulated by neurospecific alternative splicing
(Palm et al., 1998; Shimojo et al., 1999; Zuccato et al., 2003).
Here, we report that mammalian neurons have specialized
chromatin remodeling complexes as a result of the presence of
neurospecific splice variants of LSD1. A comparative analysis of
LSD1 genomic sequence across vertebrates and exon retrieval
from EST databases led us to identify four mammal LSD1 vari-
ants, generated by either single or double inclusion of two alter-
natively spliced exons, namely E2a and E8a. Thus, there are four
LSD1 isoforms: LSD1 (i.e., the conventional protein), LSD1-2a,
LSD1-8a, and LSD1-2a/8a. The former two are ubiquitous,
whereas the latter ones are restricted to the neuronal histotype.
Biochemical studies on the recombinant enzymes showed that all
three splicing isoforms retain the histone H3 Lys4 demethylase
activity displayed by the conventional LSD1. Most interestingly,
E8a results in a small protruding loop proximal to the catalytic
site as shown by the three-dimensional structure (Fig. 3).
The processing of LSD1 transcript undergoes a dynamic
modulation within the perinatal window, when fundamental
processes take place, such as phylopodia formation, neurite
sprouting (Lee and Sheng, 2000; McAllister, 2000), and the ex-
pression of the first synaptogenicmarkers. In this phase, exonE8a
inclusion frequency greatly increases, shifting the ratio toward
LSD1 neurospecific isoform production. Transcriptional profil-
ing of the developing rat brain revealed that the most dramatic
changes in gene expression occur postpartum (Stead et al., 2006),
underscoring the relevance of early postnatal life as a critical
phase of neural organization and differentiation. The dynamics
of LSD1 isoforms that we observed in vivo is fairly reproduced by
cultured cortical neurons, in which a perturbation of exon E8a-
containing isoforms results in phenotypic changes: early-stage
silencing of neurospecific isoforms delays neurite maturation,
whereas overexpression of the same enhances it, as revealed by
morphometric analysis. Notably, isoforms that are devoid of E8a
elicited no phenotypical changes relative to control, and this sug-
gests that the 4 aa peptide coded by E8a is responsible for LSD1
morphogenic effect on differentiating neurons, possibly regulat-
ing the proper timing of neurite maturation. These results relate
the “wave-like” perinatal expression of exon E8a to the acquisi-
tion of neuronal morphology, setting the basis for LSD1 role in
regulating transcription of development-related genes. Remark-
ably, an enhanced neurite complexity has already been described
in a similar cellular system by the overexpression of the methyl
binding proteinMeCP2 (Jugloff et al., 2005), whose function has
already been related to the regulation of a particular class of REST
target genes in differentiating neurons (Ballas et al., 2005).
Hints on LSD1 functional tunability come from trancrip-
tional assays performed in rat cortical neurons in which neuro-
specific exon E8a reduces LSD1 repressor activity on a reporter
gene. Several mechanisms may be proposed to explain how exon
E8a can modulate the repressor activity of LSD1: the simplest
hypothesis is that neurospecific LSD1-containing complexes reg-
ulate specific subsets of target genes that differ from those regu-
lated by ubiquitous LSD1. A second hypothesis is that the
inclusion of E8a provides a tool to tune LSD1 epigenetic activity
on shared targets. A mechanistic distinction between neurospe-
cific and ubiquitous isoforms may arise from posttranslational
modifications on E8a induced by external stimuli. The structural
analysis demonstrated that the presence of exon E8a creates a
loop protruding from the surface of the protein. This observation
suggests that exon E8a may endow LSD1 with a posttranslational
modification site, possibly having a regulatory role. This may
result in several functional alterations, including neurospecific
LSD1 affinity for CoREST or other transcriptional factors, as well
as a shift toward an activatory role (Garcia-Bassets et al., 2007;
Wang et al., 2007; Gatta and Mantovani 2008). Moreover, be-
cause the four LSD1 isoforms can be expressed within the same
neuronal type and they canmutually interact, multiple combina-
tions may occur to widen the repertoire of corepressor com-
plexes. Combinatorial assembly of neurospecific factors has
already been described (Olave et al., 2002), increasing the com-
plexity of epigenetic regulation within CNS (Lessard et al., 2007;
Wu et al., 2007). In this context, it is feasible that the recruitment
of LSD1 isoforms into CoREST complexes might be regulated by
different environmental cues, and the frequency at which the
splicing process occurs would determine the availability of such
epigenetic components.
To conclude, our work suggests that the regulated expression
of neurospecific LSD1 splice variants pacemakes early neurite
morphogenesis, prospecting important implications for LSD1
splicing in the acquisition and dynamic maintenance of the neu-
ronal phenotype by a mechanism in which different splice iso-
forms can coordinate the regulation of target genes.
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